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ABSTRACT
The aim of this paper was to discuss the embryological aspects of Müllerian duct anomalies and to analyze the current diagnostic methods and therapy. 
Müllerian anomalies are congenital defects of the female reproductive tract resulting from failure in the development of the Müllerian ducts and their 
associated structures. Their cause has yet to be fully clarified, and it is currently believed to be multifactorial. Symptoms appear principally during 
adolescence or early adulthood, and affect the reproductive capacity of these women. When clinically suspected, investigations leading to diagnosis 
include imaging methods such as hysterosalpingography, ultrasonography and magnetic resonance. The classification of these malformations relates to 
their embryogenesis, and defines the therapy and prognosis. Müllerian anomalies consist of a wide range of defects that may vary from patient to patient. 
Therefore, their management must also be individual, taking anatomical and clinical characteristics into consideration, as well as the patient’s wishes.
RESUMO
O objetivo deste trabalho foi discutir as malformações müllerianas desde seus aspectos embriológicos, analisando os atuais métodos diagnóstico e 
terapêuticos. As malformações müllerianas são anomalias congênitas do trato reprodutivo feminino decorrentes de falha do desenvolvimento dos ductos 
de Müller e estruturas associadas. Sua causa não foi completamente elucidada, acreditando-se, atualmente, que seja multifatorial. Os sintomas se 
manifestam, principalmente, durante a adolescência e início da vida adulta, e afetam a capacidade reprodutiva dessas mulheres. A partir da suspeita 
clínica, a investigação diagnóstica inclui métodos de imagem, como a histerosalpingografia, ultrassonografia e ressonância magnética. A classificação 
das malformações está relacionada à sua embriogênese e direciona a terapêutica e prognóstico. As malformações müllerianas são um grupo amplo 
de anomalias que variam de paciente para paciente. Portanto, sua abordagem também é individual, devendo-se considerar os aspectos anatômicos, 
clínicos e o desejo da paciente.
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INTRODUCTION
Müllerian duct anomalies consist of a set of structural malforma-
tions resulting from abnormal development of the paramesonephric or 
Müllerian ducts. The prevalence of these anomalies ranges from 0.001 
to 10% in the general population and from 8-10% in women with an 
adverse reproductive history.1,2 The embryological development of the 
female reproductive system is closely related to the development of the 
urinary system, and anomalies in both systems may occur in up to 25% 
of these patients.3 Other associated malformations may affect the gas-
trointestinal tract (12%) or musculoskeletal system (10-12%).3,4
Gonad formation begins between the fifth and sixth weeks of preg-
nancy, with the appearance of the urogenital ridge developing from the 
intermediate mesoderm and the migration of the germinative cells orig-
inating in the coelomic epithelium. Female development is determined 
by the absence of the Y chromosome (and consequent absence of the 
factor that determines testicle development) and by the presence of two 
X chromosomes.3,4
At around the ninth week, the ovaries are formed and the Wolff-
ian (mesonephric) and Müllerian ducts coexist. Absence of testosterone 
leads to involution of the Wolffian duct, whereas absence of anti-Mül-
lerian hormone allows differentiation of the Müllerian duct. The cau-
dal portions of these ducts merge to form the uterovaginal canal, which 
later gives rise to the cervix and uterus, as well as to the upper third of 
the vagina. Complete development of the vagina occurs through fusion 
of the structures of the urogenital sinus and the Müllerian tubercle. The 
cranial portion of the duct, i.e. the part that does not fuse, opens into 
the peritoneal cavity, giving rise to the Fallopian tubes.3,4
The causes of Müllerian anomalies have yet to be fully clarified. 
The karyotypes are normal (46 XX) in 92% of the women with Mül-
lerian anomalies and abnormal (sex chromosome mosaicism) in 8% 
of these women. The majority of these developmental abnormalities 
are infrequent and sporadic, and are thus attributed to polygenic and 
multifactorial causes.5 A recent study attributed persistence of the in-
trauterine septum to a deficiency in the antiapoptotic protein Bcl 2, 
which is responsible for the process of apoptosis and absorption of the 
septum.5
Events such as hypoxia that occur during pregnancy, the use of 
medications such as methotrexate or diethylstilbestrol (DES), ionizing 
radiation and viral infections may also contribute towards the occur-
rence of Müllerian malformations.6,7 Among the drugs that induce Mül-
lerian malformations, thalidomide and DES lead to malformations of 
the uterine cavity. DES, a nonsteroidal estrogen, was widely used in the 
1950s, principally in the United States, for treating various obstetri-
cal conditions, particularly miscarriage and preeclampsia. Consequent-
ly, anomalies consisting notably of vaginal adenocarcinoma and defor-
mations of the uterine cavity (specifically, T-shaped uterus) were iden-
tified in the daughters of women who had taken this medication.8 A 
study carried out on rats exposed intrauterinely to DES reported modi-
fications to Dkk2, Nkd2, sFRP1, hox, Wnt and Eph gene expression. 
These have been correlated with changes induced by this drug.9
In a study on cases of congenital uterine and vaginal agenesis (May-
er-Rokitansky-Küster-Hauser syndrome), possible mutations and poly-
morphisms were evaluated in the anti-Müllerian hormone gene and in 
the gene for its receptor. Analysis of the hox genes (the genes relating 
to embryogenesis) and the N314D gene (the gene that codifies the en-
zyme galactose-1-phosphate uridyl transferase [GALT] for galactose me-
tabolism) failed to find any positive correlation with the presence of 
malformations.10,11
The aim of this study was to discuss embryology, diagnostic methods 
and therapy in cases of Müllerian duct anomalies. We searched PubMed 
(National Library of Medicine, Bethesda, Maryland, United States) by 
using the following terms: “Müllerian Ducts”[Mesh] OR “Urogenital 
Abnormalities”[Mesh]. The search strategy is described in Table 1.
PHYSIOPATHOLOGY
Uterine malformations result from failure in organogenesis or from 
fusion or reabsorption of the Müllerian ducts. Failures in organogen-
esis are related to incomplete development of one or both Müllerian 
ducts, thereby leading to agenesis, uterine hypoplasia or a unicornu-
ate uterus.3
Fusion defects result from incomplete merging of the caudal por-
tion with the Müllerian ducts (lateral fusion) or incomplete merging of 
the structures of the urogenital sinus with the Müllerian tubercle (verti-
cal fusion). Failures in lateral fusion may result in uterus didelphys, bi-
cornuate uterus or arcuate uterus. When the defect occurs in vertical fu-
sion, anomalies such as imperforate hymen, transverse vaginal septum, 
oblique vaginal septum or absence of the cervix may result. Following 
caudal fusion of the ducts, the remaining portion of the central septum 
is reabsorbed. Reabsorption failure results in a uterus with a partial or 
complete septum. Certain malformations of the uterine cavity also lead 
to the formation of hypoplastic uterus, infantile uterus, agenesis of the 
cervix and T-shaped uterus.3
CLASSIFICATION
The definition of uterine anomalies proposed by the American Fer-
tility Society12 classifies uterine malformations into seven separate cat-
egories:
Class I: Hypoplasia/uterine agenesis.
Class II: Unicornuate uterus:
a) Has a functioning endometrium and communication with the main 
uterine cavity.
Database Strategy Result
PubMed*
“Müllerian Ducts”[Mesh]
OR “Urogenital
Abnormalities”[Mesh]
161 clinical trials
43 randomized controlled trials
4 meta-analyses
1451 case reports
8 practice guidelines
Lilacs (Literatura 
Latino-Americana 
e do Caribe em 
Ciências da 
Saúde)
9 clinical trials
46 case reports
25 reviews 
1 practice guideline
1 epidemiological study
Cochrane 22 clinical trials
*Limits: added to PubMed in the last 10 years; Female; English; Portuguese.
Table 1. Database search results
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b) Also has an endometrial structure that responds to hormonal stim-
ulus; however, there is no communication with the external genital 
tract.
c) Has a rudimentary structure with no activity, attached to a more 
fully developed uterine horn. 
d) Results from the development of only one Müllerian duct, with 
complete agenesis of the contralateral duct.  
Class III: Uterus didelphys.
Class IV: Bicornuate uterus:
a) Complete: when the indentation produced in the fundic region is 
deep, thus indicating that fusion failed from the level of the cervical 
region.
b) Incomplete: when the division is higher, not extending to the level 
of the cervix, indicated by the shallower indentation in the contour 
of the region of the uterine fundus.
Class V: Septate uterus:
a) When the septum extends into the internal cervical ostium, possi-
bly including the cervical canal, and divides the cervix into two tun-
neled cavities. A vaginal septum is often also present.
b) When the septum does not divide the uterine cavity along its entire 
length, and circulation exists between the two chambers.
Class VI: Arcuate uterus: 
This is a rather insignificant anomaly of the uterine cavity in which, 
generally, no abnormalities in the external contour of the uterus are visi-
ble. The small fundal cleft or impression with a protruding uterine horn 
becomes more noticeable during pregnancy.
Class VII: T-shaped uterus resulting from the use of DES.
CLINICAL IMPLICATIONS
Müllerian anomalies are frequently asymptomatic and are often 
missed in routine gynecological examinations. Nevertheless, a history 
of pelvic pain following the menarche, dysmenorrhea and an increase 
in abdominal volume are complaints suggestive of uterine anomalies. 
In addition, primary amenorrhea and changes to menstrual flows may 
be present.13
Among the ductal differentiation malformations, vaginal agenesis 
presents with primary amenorrhea and dyspareunia. In cases of uteri 
with a functional endometrium, hematometra and hematocolpos are 
frequent findings. 
A unicornuate uterus is seldom symptomatic unless associated with 
other malformations. If a rudimentary, noncommunicating uterine 
horn is present together with a functional endometrium, hematometra 
and sometimes hematosalpinges may be found.14
The clinical presentation of anomalies associated with defects in fu-
sion and reabsorption of the septum varies clinically according to the 
Miscarriage
(%)
Premature delivery
(%)
Fetal survival
(%)
Septate uterus3,14,16 > 60 - 6-28
Unicornuate uterus17 43.8 25 43.7
Uterus didelphys11 35 19 60
Bicornuate uterus 4017 - 6217
Table 2. Reproductive prognosis
duct segment affected. The presence of a vaginal septum is perceived 
by patients as an obstacle to sexual relations and may be confirmed by 
speculum examination. When the menstrual flow is obstructed, patients 
may report pain.12
Uterine septum is generally an asymptomatic condition and is often 
only diagnosed when couples with a history of repeated miscarriage or 
infertility are undergoing investigation. Likewise, lateral fusion defects, 
which are responsible for uterus didelphys and bicornuate uterus, are of-
ten detected only when women undergo imaging tests.12
Anomalies resulting from failure in vertical fusion, such as cervical 
agenesis, transverse vaginal septum and imperforated hymen, are associ-
ated with primary amenorrhea, hematocolpos and hematometra.15
The reproductive prognosis for patients with Müllerian malforma-
tions is shown in Table 2.3,12,16-19 The hypotheses developed to explain 
the poor obstetrical prognosis for women with the diverse Müllerian 
malformations include decreased intraluminal volume; inadequate vas-
cularization of regions such as the septum; presence of a medial wall or 
an unfused uterine horn; and greater uterine contractility and irritabil-
ity, thereby leading to miscarriages and premature deliveries.12
DIAGNOSIS
Due to the complexity of presentations, diagnosing of Müllerian 
malformations requires the use of more than one imaging method in 
62% of the cases.20,21 Hysterosalpingography (HSG) is the method tra-
ditionally used to evaluate the cervical canal, uterine cavity and Fallo-
pian tubes. Its efficacy in diagnosing anomalies is debatable and varies 
according to the specific type of malformation.20 The specificity values 
range from 6 to 60%, depending on the malformation investigated and 
the technician’s skill.1,22 HSG enables accurate evaluation of tube per-
meability and can detect the presence of uterine septa, intrauterine syn-
echiae, submucous fibroids and endometrial polyps. However, it cannot 
be performed on patients who are virgins and it does not allow the ex-
ternal uterine anatomy to be viewed, which hampers the differential di-
agnosis between uterus didelphys and septate uterus.3,22,23 Moreover, the 
method exposes the patient to ionizing radiation; the injection of con-
trast may cause allergies and discomfort; and there is also a risk of uter-
ine perforation and infection.1
Ultrasonography has a sensitivity of around 44%, varying accord-
ing to the specific type of malformation under evaluation, the patient’s 
body composition, the radiologist’s experience and the type of transduc-
er used. Transvaginal ultrasonography allows a more detailed analysis of 
the endometrium, uterine cavity and cervix. The specificity of this ex-
amination ranges from 85 to 92%.24-26 Recently, three-dimensional ul-
trasonography has shown high specificity and sensitivity in evaluations 
on all uterine anomalies, including Müllerian malformation.27
The specificity of magnetic resonance imaging (MRI) ranges from 
96 to 100% for diagnosing Müllerian malformations.1 In cases of uter-
ine hypoplasia, the images show a small endometrial cavity and a short-
er distance between the uterine horns.20 In these patients, the presence 
of ovaries and associated renal malformations can also be evaluated. In 
cases of unicornuate uterus, a small endometrial cavity with only one 
Fallopian tube is seen. A rudimentary uterine horn may be present and, 
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if there is no communication with the cervical canal, the accumulated 
retrograde menstruation will be easily seen.20
Uterus didelphys is visible in axial sections, which show two sepa-
rate chambers. However, the anatomy of the wall is intact. A vaginal 
septum may or may not be present.20
The MRI criteria for diagnosing a bicornuate uterus consist of 
the presence of divergent uterine horns and concavity at the contour 
of the uterine fundus. This type of anomaly appears as a heart-shaped 
uterus. On the other hand, in cases of septate uterus, the external con-
tour of the uterus is normal and the septum is seen as a difference in 
signal intensity, according to its composition. Fibrous septa are seen as 
low-intensity signals on T2-weighted images and muscular septa as in-
termediate-intensity T2 signals.28 Nowadays, cytogenetic analysis on pa-
tients with developmental anomalies of the Müllerian ducts may only 
be useful for family counseling.29
THERAPEUTIC MANAGEMENT
The treatment for Müllerian anomalies varies according to the spe-
cific type of malformation found in each patient. A systematic search 
(descriptor: Müllerian anomalies or uterine anomalies, default tag: Ti-
tle/Abstract) was conducted in the Lilacs, PubMed and Cochrane data-
bases. Two randomized controlled trials were identified.30,31 Most of the 
studies on therapeutic issues (827 studies) were restricted to reports on 
single cases or small series.
Anomalies of the vaginal septum should be resected at the time of 
diagnosis, thereby resolving problems of dyspareunia and permitting 
adequate drainage of menstrual flow.32
Patients with a confirmed diagnosis of cervical agenesis should be 
referred for hysterectomy, preferentially performed laparoscopically. 
Several surgical attempts to create a cervix have resulted in tragic out-
comes, often associated with fatal complications.19 The prospects for 
pregnancy using in vitro fertilization techniques should be evaluated 
in the light of the obstetrical complications, and possible alternatives 
should be offered to these women. The use of a surrogate womb may 
be the best option in such cases. In cases of uterine septum, the resec-
tion should be performed hysteroscopically, in order to improve the re-
productive prognosis for these patients by decreasing the incidence of 
miscarriage, premature delivery and infertility.17 The advantages of hys-
teroscopy include the shorter duration of surgery, smaller blood loss, 
lower costs, reduced morbidity and shorter hospital stay, compared with 
abdominal surgery.30,31 
In cases of complete uterine septum, resection of the cervical sep-
tum may be related to cervical incompetence and secondary infertility. 
A randomized controlled trial performed to evaluate the safety and ef-
ficacy of resection of the cervical septum during hysteroscopic metro-
plasty showed that this procedure was safer and easier with resection 
than with preservation of the cervical septum.32 
The use of estrogen therapy or an intrauterine device are post-
surgical alternatives for minimizing formation of uterine adherences 
(synechiae).32,33 The follow-up in these cases includes hysteroscopy, one 
to three months after the initial surgery.31 Laparoscopy should be used 
to excise obstructed, rudimentary uterine horns and adjacent tubes in 
patients with a unicornuate uterus. It should also be used for hysterec-
tomy in cases of cervical agenesis and in neovaginoplasty procedures in 
cases of vaginal agenesis.19 In many women, the malformation results 
in obstructed and retrograde menstruation, thereby facilitating the de-
velopment of endometriosis. During laparoscopy, this diagnosis may be 
confirmed and the endometrial foci may be resected.
CONCLUSIONS
Müllerian anomalies consist of a wide range of defects that may vary 
from patient to patient. Therefore, their management must also be indi-
vidual, taking anatomical and clinical characteristics into consideration, 
as well as the patient’s wishes.
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